Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02633 JACOBSON PHARMA
RTNominal up0.590 +0.010 (+1.724%)
Others

11/10/2019 12:13

Jacobson Pharma (02633) CEO Derek Sum buys more shares

[ET Net News Agency, 11 October 2019] Jacobson Pharma Corporation Limited (02633)
announced that Queenshill Development Limited, wholly owned by Derek Sum, chief executive
officer, chairman and controlling shareholder of the group, has acquired 1 million shares
on 8 October 2019 with an average purchase price of HK$1.1239 per share. Also, Raymond
Yim, an executive director of the group, has acquired an aggregate of 400,000 shares
between 3 October to 8 October 2019, with an average price ranging from HK$1.1183 to
HK$1.1975.
Increase stake of the group further proves shareholders' confidence in the company's
fortified position to deliver sustainable growth over the long term. (RC)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.